190 related articles for article (PubMed ID: 18596088)
1. Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.
DeHart JL; Bosque A; Harris RS; Planelles V
J Virol; 2008 Sep; 82(18):9265-72. PubMed ID: 18596088
[TBL] [Abstract][Full Text] [Related]
2. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
Liu B; Sarkis PT; Luo K; Yu Y; Yu XF
J Virol; 2005 Aug; 79(15):9579-87. PubMed ID: 16014920
[TBL] [Abstract][Full Text] [Related]
4. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
Zhang W; Huang M; Wang T; Tan L; Tian C; Yu X; Kong W; Yu XF
Cell Microbiol; 2008 Aug; 10(8):1662-75. PubMed ID: 18419775
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
[TBL] [Abstract][Full Text] [Related]
7. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
[TBL] [Abstract][Full Text] [Related]
8. The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation.
Kim DY
Arch Pharm Res; 2015 Apr; 38(4):435-45. PubMed ID: 25408426
[TBL] [Abstract][Full Text] [Related]
9. Lineage-Specific Viral Hijacking of Non-canonical E3 Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity.
Kane JR; Stanley DJ; Hultquist JF; Johnson JR; Mietrach N; Binning JM; Jónsson SR; Barelier S; Newton BW; Johnson TL; Franks-Skiba KE; Li M; Brown WL; Gunnarsson HI; Adalbjornsdóttir A; Fraser JS; Harris RS; Andrésdóttir V; Gross JD; Krogan NJ
Cell Rep; 2015 May; 11(8):1236-50. PubMed ID: 25981045
[TBL] [Abstract][Full Text] [Related]
10. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
11. Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors.
Binning JM; Smith AM; Hultquist JF; Craik CS; Caretta Cartozo N; Campbell MG; Burton L; La Greca F; McGregor MJ; Ta HM; Bartholomeeusen K; Peterlin BM; Krogan NJ; Sevillano N; Cheng Y; Gross JD
PLoS Pathog; 2018 Jan; 14(1):e1006830. PubMed ID: 29304101
[TBL] [Abstract][Full Text] [Related]
12. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
[TBL] [Abstract][Full Text] [Related]
13. Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.
Baig TT; Feng Y; Chelico L
J Virol; 2014 Dec; 88(24):14380-95. PubMed ID: 25275135
[TBL] [Abstract][Full Text] [Related]
14. Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins.
Zhang J; Wu J; Wang W; Wu H; Yu B; Wang J; Lv M; Wang X; Zhang H; Kong W; Yu X
Retrovirology; 2014 Sep; 11():77. PubMed ID: 25213124
[TBL] [Abstract][Full Text] [Related]
15. Interaction between HIV-1 and APOBEC3 sub-family of proteins.
Arriaga ME; Carr J; Li P; Wang B; Saksena NK
Curr HIV Res; 2006 Oct; 4(4):401-9. PubMed ID: 17073615
[TBL] [Abstract][Full Text] [Related]
16. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA; Pathak VK
J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
18. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
Zhang W; Chen G; Niewiadomska AM; Xu R; Yu XF
PLoS One; 2008; 3(12):e3963. PubMed ID: 19088851
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.
Mehle A; Goncalves J; Santa-Marta M; McPike M; Gabuzda D
Genes Dev; 2004 Dec; 18(23):2861-6. PubMed ID: 15574592
[TBL] [Abstract][Full Text] [Related]
20. MDM2 is a novel E3 ligase for HIV-1 Vif.
Izumi T; Takaori-Kondo A; Shirakawa K; Higashitsuji H; Itoh K; Io K; Matsui M; Iwai K; Kondoh H; Sato T; Tomonaga M; Ikeda S; Akari H; Koyanagi Y; Fujita J; Uchiyama T
Retrovirology; 2009 Jan; 6():1. PubMed ID: 19128510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
